The Australian developer of synthetic cannabidiol and psychedelic medicine therapies, Incannex Healthcare, has filed a registration statement with the Securities Exchange Commission (SEC) for the a proposed IPO of ADS…
The Australian developer of synthetic cannabidiol and psychedelic medicine therapies, Incannex Healthcare, has filed a registration statement with the Securities Exchange Commission (SEC) for the a proposed IPO of ADS…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference